IGNE Stock: Igene Biotechnology, Inc. Stock Price, Analysis & Insights

Get live IGNE stock price $0.00, comprehensive Igene Biotechnology, Inc. stock analysis, charts, news, and expert forecast. Real-time IGNE stock data and investment insights.

Quick links:Financial Metrics•Earnings•Analyst Forecasts•Financials•Technicals

0.00

0.00%Today

IGNE • Igene Biotechnology, Inc. • Other OTC • Basic Materials

Market Cap

15.65K

Volume

50.56K

52W High

0.00

52W Low

0.00

Loading chart data...

Investment Score

Annual (latest period)

Unavailable

A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.

Score unavailable for this asset.

View full dashboardUnlock quarterlyFaster signals · Pro+

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Igene Biotechnology, Inc. is dedicated to the discovery, development, production, and commercialization of specialized ingredients for both human and animal nutrition. A key offering from the company is natural astaxanthin, a valuable nutrient utiliz...

Contact Information

Website: https://www.igene.com
Address: 9110 Red Branch Road
Country: US

Investment Analysis & Business Insights

Basic Materials

Agricultural Inputs

Investment Highlights

✓ Strong presence in the Basic Materials sector with established market position

✓ Lower volatility stock (Beta: -23.34) may provide portfolio stability

Important Investment Considerations

⚠All investments carry risk, including potential loss of principal for Igene Biotechnology, Inc. shareholders
⚠Market volatility can significantly impact stock price, especially for smaller companies
⚠Sector-specific risks in Basic Materials may affect company performance
⚠Past performance does not guarantee future results for Igene Biotechnology, Inc.
⚠Investors should consider how Igene Biotechnology, Inc. fits within their overall portfolio allocation

Market Cap

15.65K

Beta

-23.34

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.